Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy

Update Il y a 4 ans
Reference: NCT00984802

Woman and Man

Extract

This study is conducted to assess the safety of CMX-2043 solution for intravenous (IV) injection, and to evaluate efficacy on the basis of the changes seen in the cardiac biomarkers and continuous electrocardiography (ECG) monitoring. Additionally, correlation of the levels/changes in the biomarkers and the pharmacokinetic evaluations of the drug will be explored.


Inclusion criteria

  • Stable Coronary Artery Disease ,Percutaneous Coronary Intervention

Links